Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.

@article{Aher2006LateEF,
  title={Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.},
  author={Sanjay M Aher and Arne Ohlsson},
  journal={The Cochrane database of systematic reviews},
  year={2006},
  volume={3},
  pages={
          CD004868
        }
}
BACKGROUND Hematocrit falls after birth in preterm infants due to physiological factors and blood letting. Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anemia. OBJECTIVES PRIMARY OBJECTIVE To assess the effectiveness and safety of late initiation of EPO (initiated at 8 days after birth or later) in reducing the use of red blood cell transfusions in preterm and/or low birth weight infants. SECONDARY OBJECTIVES… CONTINUE READING